|
Originally published In Press as doi:10.1074/jbc.M002040200 on April 11, 2000
J. Biol. Chem., Vol. 275, Issue 30, 23113-23119, July 28, 2000
Mutational Analysis of '260-309, a
70 Binding Site Located on Escherichia coli
Core RNA Polymerase*
Terrance M.
Arthur §,
Larry C.
Anthony §, and
Richard R.
Burgess ¶
From the McArdle Laboratory for Cancer Research and
the § Department of Bacteriology, University of Wisconsin,
Madison, Wisconsin 53706
Received for publication, March 10, 2000, and in revised form, April 9, 2000
 |
ABSTRACT |
In eubacteria, the subunit binds to the core
RNA polymerase and directs transcription initiation from any of its
cognate set of promoters. Previously, our laboratory defined a region of the ' subunit that interacts with 70
in vitro. This region of ' contained heptad repeat
motifs indicative of coiled coils. In this work, we used 10 single
point mutations of the predicted coiled coils, located within residues
260-309 of ', to look at disruption of the 70-core
interaction. Several of the mutants were defective for binding 70 in vitro. Of these mutants, three (R275Q,
E295K, and A302D) caused cells to be inviable in an in vivo
assay in which the mutant ' is the sole source of ' subunit for
the cell. All of the mutants were able to assemble into the core
enzyme; however, R275Q, E295K, A302D were defective for
E 70 holoenzyme formation. Several of the mutants were
also defective for holoenzyme assembly with various minor factors.
In the recently published crystal structure of Thermus
aquaticus core RNA polymerase (Zhang, G., Campbell, E. A.,
Minakhin, L., Richter, C., Severinov, K., and Darst, S. A. (1999)
Cell 98, 811-824), the region homologous to
'260-309 of Escherichia coli forms a coiled
coil. Modeling of our mutations onto that coiled coil places the most
defective mutations on one face of the coiled coil.
 |
INTRODUCTION |
The DNA-dependent RNA polymerase
(RNAP)1 is a multisubunit
enzyme that plays a central role in eubacterial gene regulation and
expression. This enzyme has two functional forms: core and holoenzyme.
Transcription elongation and termination are performed by the core
enzyme with :2, :1, ':1 stoichiometry (1). Core RNAP binds one
of a variety of subunit species at a given time to form a specific
holoenzyme (2). The holoenzyme performs the tasks of promoter
recognition and transcription initiation. Each subunit directs its
cognate holoenzyme to start transcription from only those promoters
containing DNA sequences specifically recognized by that factor
(2-4).
Understanding the molecular basis of binding to core RNAP will aid
in the analysis of several questions involving how multiple species
come to sequester core and turn on subsequent genes. It has been
hypothesized that all of the species bind to the same site/sites on
the core enzyme (1, 6, 7). Studies to identify the core binding site on
have resulted in the positive identification of a single binding
site located on 70 overlapping conserved region 2.1 (5,
8). A single point mutation in the homologous region of Bacillus
subtilis E prevented binding to core (9). More
recent genetic and biochemical studies suggest that region 2.1 may be
only one of multiple contact sites that uses in binding to the core
enzyme (6, 10, 11).
Information about sites on core that bind has come in most part
from biochemical assays. Protein footprinting studies of the core
enzymes susceptibility to hydroxy radical cleavage upon binding a
modified factor containing the cleavage catalyst have revealed that
there are three regions on the core, one located on ' and two on
, that are in close proximity to (12). One of the regions
was identified earlier as being near the 70 binding
region. It was noticed that this site, in the core enzyme complex, was
cleaved by trypsin, whereas formation of E 70 prevented
trypsin cleavage at this site (13). Previous in vitro work
from our laboratory identified a strong binding site for 70 on the ' subunit (14). This site was mapped to
within residues 260-309 of '.
The predicted secondary structure (15) of '260-309 has
two helices joined by a random coil. Another structural analysis
program indicates that these two helices are amphipathic and have the
potential for coiled coil formation (16). The coiled coil motif is
based on a heptad repeat of residues designated a-g (17, 18) (Fig.
1B). The a and d positions are hydrophobic, whereas the
other positions are usually charged or polar. Burial of the a and d
hydrophobic residues during coiled coil formation provides a large
amount of the binding energy. Specificity in binding comes from the e
and g positions, which can form ionic interactions or salt bridges.
We have undertaken a mutational analysis of this region to confirm that
our in vitro binding results were relevant to in
vivo binding and function. This work presents the analysis of 10 point mutations, most of which are change-of-charge mutations at the e
and g residues, in the '260-309 predicted coiled coil. Three of the mutations (R275Q, E295K, and A302D) were nonfunctional in
binding 70 in all of the assays in which they were
tested but still able to assemble into the core enzyme. We also report
on mutations that were nonfunctional in some of our assays but
functional in others, indicating that binding of other sites may
compensate for loss of binding at the '260-309 site. We
use this analysis to demonstrate that the binding site identified
previously by in vitro methods is important in
vivo and that mutations in this region can greatly diminish core
binding of 70 and other minor s. In the recently
solved crystal structure for the core RNAP of Thermus
aquaticus, the region homologous to Escherichia coli
'260-309 was determined to form a "coiled coil-like" structure (19) consistent with our predictions. Modeling of our mutations onto the T. aquaticus structure places all
of the nonfunctional mutations on the same face of the ' coiled coil.
 |
EXPERIMENTAL PROCEDURES |
Construction of Plasmids--
Plasmid characteristics are
described in Table I. Plasmids pTA577 and
600-620 were made from the base plasmid pRL663 (20). Single
HinDIII and BamHI restriction sites, at bases 674 and 952 of rpoC, respectively, were inserted into the
rpoC gene of pRL663 via silent mutagenesis to create pTA577.
pTA561 was created in the same manner as pTA577 except that pRL308 (22)
was the starting plasmid. The HinDIII and BamHI
restriction sites were used to insert polymerase chain
reaction-generated DNA fragments containing the various mutations to
generate pTA600-609. For pTA620, which contains a truncated
rpoC fragment coding for ' residues 1-319, pRL663 was
cut with Xba-HinDIII for insertion of a polymerase chain
reaction-generated rpoC truncation. The 70
binding site was previously mapped to residues 260-309 of '; however, we engineered some of the constructs for this work to extend
to residue 319. This was done to incorporate the BamHI site
mentioned previously. Therefore, the various mutations could be moved
into the new plasmid to create pTA610-619. We have not seen any
difference in behavior of the fragments ending at residue 309 as
opposed to those ending at residue 319. All sequences generated via
polymerase chain reaction were sequenced to ensure that spurious mutations had not been incorporated.
Expression and Purification of 70--
The cells
were grown to an A600 of 0.6-0.8 in 1-liter
cultures at 37 °C in LB medium with 100 µg/ml ampicillin.
Isopropyl- -D-thiogalactopyranoside was then added to a
concentration of 1 mM. Three hours after induction, the
cells were harvested by centrifugation at 8,000 × g
for 15 min and frozen at -20 °C.
The cell pellet from a 1-liter culture was thawed and resuspended in 10 ml of lysis buffer (40 mM Tris, pH 7.9, 0.3 M
KCl, 10 mM EDTA, and 0.1 mM
phenylmethylsulfonyl fluoride), and lysozyme was added to 0.1 mg/ml.
The cells were incubated on ice for 15 min and then sonicated in three
60-s bursts. The recombinant protein in the form of inclusion bodies
was separated from the soluble lysate by centrifugation at 27,000 × g for 15 min. The inclusion body pellet was resuspended
by sonication in 10 ml of lysis buffer + 2% (w/v) sodium deoxycholate.
The mixture was centrifuged at 27,000 × g for 15 min,
and the supernatant was discarded. The deoxycholate-washed inclusion
bodies were resuspended in 10 ml of deionized water and centrifuged at
27,000 × g for 15 min. The water wash was repeated,
and the inclusion bodies were aliquoted into 1-mg pellets and frozen at
20 °C until use.
70 inclusion bodies (10 mg) were solubilized, refolded,
and purified according to a variation of the procedure of Gribskov and
Burgess (21). The inclusion bodies were solubilized by resuspension in
10 ml of 6 M guanidine-HCl. The proteins were allowed to
refold by diluting the denaturant 64-fold with Buffer A (50 mM Tris, pH 7.9, 0.5 mM EDTA, and 5% (v/v)
glycerol) in 2-fold steps over 2 h. One gram of resin
(DEAE-cellulose, Whatman) was added and mixed with slow stirring for
24 h at 4 °C. The resin was then collected in a 10-ml column
and washed, and the protein was eluted with a gradient from 0.1 to 1.0 M NaCl in Buffer A. The 70 fractions were
pooled, dialyzed overnight against 1 liter of storage buffer (50 mM Tris, pH 7.9, 0.5 mM EDTA, 0.1 M
NaCl, 0.1 mM dithiothreitol, and 50% (v/v) glycerol), and
stored at 20 °C.
Quantitative Western Blotting--
Protein samples to be
quantitated were subjected to SDS-polyacrylamide gel electrophoresis.
The proteins were electrophoretically transferred out of the gel onto
0.05-µm nitrocellulose. The blot was blocked in Blotto (10 mM Tris, pH 7.4, 150 mM NaCl, 0.1% (v/v) Tween
20, and 3% (w/v) nonfat dry milk) and probed with monoclonal antibodies. The signal was generated using the ECL Plus system (Amersham Pharmacia Biotech) and detected on a Storm PhosphorImager (Molecular Dynamics). The signal was quantitated using ImageQuant software (Molecular Dynamics).
Far Western Blotting--
Cells containing truncated '
expression plasmids pTA610-620 were grown to
A600 = 0.6-0.8 and induced with 1 mM isopropyl- -D-thiogalactopyranoside. The
cells were grown for an additional 30 min. A 200-µl sample was
removed and sonicated three times for 30 s each. 20 µl of glycerol and 20 µl of SDS sample buffer were added and heated for 2 min at 95 °C, and the sample was then stored at -20 °C until use. The lysates were separated by SDS-polyacrylamide gel
electrophoresis. The proteins were electrophoretically transferred onto
0.05-µm nitrocellulose. The nitrocellulose was blocked by incubating
in HYB buffer (20 mM Hepes, pH 7.2, 200 mM KCl,
2 mM MgCl2, 0.1 µM ZnCl2, 1 mM dithiothreitol, 0.5% (v/v) Tween
20, 1% (w/v) nonfat dry milk) for 16 h at 4 °C. A chimeric
70 was created by fusing a heart muscle kinase
recognition sequence to the N terminus of 70 to
facilitate radiolabeling of 70. Labeling of
70 was done in a 100-µl reaction volume. 50 µl of
2× kinase buffer (40 mM Tris, pH 7.4, 200 mM
NaCl, 24 mM MgCl2, 2 mM
dithiothreitol) was added to 50 µg of heart muscle kinase
70 protein. 240 units of cAMP-dependent
kinase catalytic subunit (Promega) was added and the total volume was
brought to 99 µl with deionized water. One microliter of
[ -32P]ATP (0.15 mCi/µl) was added. The mixture was
incubated at room temperature for 30 min. The reaction mixture was then
loaded onto a Biospin-P6 column (Bio-Rad) preequilibrated with 1×
kinase buffer and centrifuged at 1100 × g for 4 min.
The flow-through was collected and stored at 20 °C.
The blocked nitrocellulose was incubated in 10 ml of HYB buffer with
4 × 105 cpm/ml 32P-labeled
70 for 3 h at room temperature. The blot was washed
three times with 10 ml of HYB buffer for 3 min each. The blot was
dried, and the signal was visualized with a PhosphorImager and
quantitated with ImageQuant software (Molecular Dynamics).
Growth Assessment--
Plasmids pTA577 and 600-609 (0.1 µg)
were transformed into strain RL602 (22, 23). After heat shock and
incubation on ice, 300 µl of LB was added to the 50-µl cell
mixture. 10 µl of the transformation reaction was spotted onto LB
plates plus ampicillin (100 µg/ml) and incubated at 30 °C. Another
10 µl was spotted onto identical plates and incubated at 42 °C.
The plates were incubated for 24-48 h and assessed for growth.
Purification of Core/Holo Complexes--
1-liter flasks
containing 200 ml of LB with ampicillin (100 µg/ml) and
isopropyl- -D-thiogalactopyranoside (0.15 mM) were inoculated with 200 µl from overnight cultures
of cells containing plasmids pTA561, 577, and 600-609. The cultures
were grown at 37 °C with shaking until the
A600 reached 0.4 for log phase assays and 2 h longer (A600 ~ 2.0) for the early stationary
phase assays. The cells were harvested by centrifugation at 6,000 × g for 10 min and stored at -20 °C until use. The cell
pellets were resuspended in 5 ml of TE (10 mM Tris, pH 7.9, and 0.1 mM EDTA) plus 0.15 M NaCl and lysozyme
(0.1 mg/ml) and then incubated on ice for 15 min. The cells were
sonicated three times for 30 s each and centrifuged for 25 min at
27,000 × g to remove the insoluble material. The
supernatant was loaded onto a 1.5-ml immunoaffinity column containing
the polyol-responsive, anti- ' monoclonal antibody NT73 (24). The
column was washed with 15 ml of TE plus 0.15 M NaCl
followed by a second wash with 10 ml of TE plus 0.5 M NaCl. The protein was eluted from the column with 4 ml of TE plus 0.7 M NaCl and 30% propylene glycol. The eluted sample (4 ml)
was diluted with 6 ml of buffer 66 (20 mM Tris, pH 7.9, 500 mM NaCl, 5 mM imidazole, 0.1% (v/v) Tween 20, and 10% (v/v) glycerol) and loaded (2×) onto 500 µl of
Ni2+-NTA resin. The resin was washed twice with 5 ml of
buffer 66 and eluted with 0.5 ml of buffer 66 plus 0.25 M
imidazole. Samples from the elution fractions were assayed by Western
blot as described above, using monoclonal antibodies to each subunit or
factor. The secondary antibodies were horseradish
peroxidase-labeled goat anti-mouse IgG antibodies and the signal was
generated using the ECL Plus substrate system (Amersham Pharmacia
Biotech) and detected using the STORM PhosphorImager and quantitated
with ImageQuant software (Molecular Dynamics).
 |
RESULTS |
Mutational Design--
Structural prediction, using the Coils
program (16), scored both of the predicted -helices of
'260-309 as having a high probability of forming coiled
coils (Fig. 1A). To test this
prediction, we constructed two ' mutants with proline residues inserted into either helix. These ' mutants were no longer predicted to form helices or coiled coils. When assayed for function in both the
far Western and in vivo growth assays, both mutants were found to be nonfunctional (data not shown). We took this to indicate that the helical/coiled coil structure in this region was important for
function. The solubility of these mutant proteins was not 100%, so we
ceased using them because their loss of function could simply be due to
gross folding defects. We decided to concentrate in most part on the e
and g positions of the -helices for the next phase of our analysis.
The e and g residues of coiled coils often engage in interhelical
interactions, such as the formation of ionic interactions or salt
bridges (17, 18). Such interactions in this case could be
intramolecular (between the two helices of '260-309),
forming a coiled coil structure necessary for binding by the subunit (Fig. 1B). Alternatively, the e and g residues of
'260-309 could be making intermolecular contacts with
upon binding. Our efforts were directed toward making
change-of-charge mutations at these residues of ' (Fig.
1B) and assaying their effects on binding. Two of the
mutations described in this work do not involve e or g residues and
were chosen for other reasons. Based on the findings that tyrosine and
arginine residues are often located in "hot spots" of
protein-protein interactions (26), we changed the tyrosine residue at
position 269 to an alanine and arginine 297 to a serine. Previous
studies in our laboratory found that insertion of a leucine at position
297 generated a ' subunit that was nonfunctional for binding
70 (unpublished results). Therefore, we were interested
to determine whether a less drastic mutation at this position would
also affect binding.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 1.
The
"260-309 region. A,
schematic diagram of '260-309 interaction domain. The
lettered boxes represent the conserved regions of the
largest subunits of the eukaryal and prokaryal RNAP (45). The
'260-309 interaction domain overlaps part of the '
subunit conserved region 66. Below the interaction domain
are diagrams of the predicted helices and coiled coils.
B, hypothetical helical wheel drawing of predicted
'260-309 coiled coil. The two predicted helices are
shown as interacting with one another to form an antiparallel coiled
coil. Mutations are shown next to original residues along with the
residue number. The N terminus is at amino acid Asn-266 on the
right helix. The right helix is drawn as coming
out of the page, whereas the left helix is drawn as going
into the page and terminates at Asn-309.
|
|
Several of the Mutations in the '260-319 Region
Disrupt Interaction with 70 in a Far Western
Assay--
Previously, we had used far Western blotting to map a
70 binding site to the N-terminal region of the '
subunit (14). We again applied this procedure as an initial assay for
functionality of our ' mutants. The mutations were cloned into a
gene fragment coding for amino acids 1-319 of the ' subunit. Cells
containing these genes were induced for a short period to give moderate
levels of the ' fragment, comparable to other proteins in the
extract. Samples were analyzed for binding 70 by far
Western analysis as described under "Experimental Procedures." The
amount of 70 probe bound by each '1-319
mutant fragment was compared with the amount bound by wt
'1-319 fragment. Each signal was normalized to the
amount of '1-319 contained in the supernatant as
determined by Western blotting.
Five of the mutations (R275Q, R293Q, E295K, R297S, and A302D) were
greatly reduced in their ability to bind 70 (Fig.
2). The Q300E and N309D mutations had the
opposite effect, binding more 70 than wild type
'1-319. Q300E exhibited an increase in relative binding
of greater than 7-fold. There were no effects on binding seen with the
N266D, Y269A, or K280E mutations.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 2.
Western and far Western blots of cell
extracts containing wt or mutant
'1-319. Cell extracts of
the indicated ' mutants were separated by 8-16% Tris-glycine
SDS-polyacrylamide gel electrophoresis, blotted to nitrocellulose, and
probed with an anti- ' antibody (A) or
32P-labeled 70 (B). C,
relative binding of 70 by wt and mutant ' fragments.
The values for relative 70 binding by wt
versus mutant '1-319 fragments determined
from far Western blotting analysis were normalized to the amount of
'1-319 fragment loaded as determined by quantitative
Western blot analysis (wt = 1.0). Error bars represent
S.D. Results are the average of three different experiments.
|
|
Complementation with Mutant ' Subunits--
To assess the
importance of the 70 binding site in vivo, we
assayed the ability of mutant ' subunits to function as the sole source of ' for the cell. Plasmids containing mutant or wild type,
full-length ' were transformed into strain RL602 (22, 23). The
chromosomal rpoC gene of RL602 has an amber mutation that
prevents functional ' from being produced in the absence of a
suppressor tRNA. RL602 also has a chromosomal, temperature-sensitive amber suppressor. At the permissive temperature (30 °C), the amber suppressor is active and allows chromosomal ' to be produced and the
cell can grow. The amber suppressor is not active at the nonpermissive
temperature (42 °C). Therefore, at 42 °C, chromosomal ' is not
made, and the cell cannot grow without another source of '. If the
plasmid-derived ' can complement the loss of ', then the cells
will grow and form colonies on plates at the nonpermissive temperature.
If the mutant ' cannot complement, there will be no growth on the
plates at this temperature.
Three of the ' mutants that were defective for binding in the
far Western assay (R275Q, E295K, and A302D) could not support growth at
the nonpermissive temperature, indicating that these mutations were
also caused defects in binding in vivo (Fig. 3). N266D, a mutation that had no
detectable effect in the far Western assay, allowed some growth at the
nonpermissive temperature but not enough to be considered wild type. In
contrast, the R293Q and R297S mutations that did not bind
70 in the far Western assay could support growth
in vivo. Mutations Y269A, K280E, Q300E, and N309D had no
detectable effects on growth. Expression levels for nonfunctional '
mutants were determined to be equivalent to that of plasmid-derived,
wild type ' when grown at 37 °C (data not shown).

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 3.
Growth with plasmid-derived wt or mutant
' as the sole source of '
subunit. Strain RL602 was transformed with plasmids encoding
either wt or mutant full-length '. Transformed cells (10 µl) were
then spotted onto duplicate plates, incubated at either 30 °C
(permissive) or 42 °C (nonpermissive) for 24-48 h, and then
assessed for growth.
|
|
Effects of ' Mutations on Core/Holoenzyme Assembly--
An
alternate explanation for the inviability caused by some of the '
mutations would be that they are no longer able to be assembled into
the core enzyme. To evaluate the potential assembly defects caused by
the various mutations, we expressed His6-tagged, mutant
' subunits in cells that were also expressing wild type, chromosomal
' proteins. We used a Ni2+-NTA mediated pull-out assay
to purify the mutant subunits together with associated cell
proteins. An immunoaffinity column was used to clean up the samples in
order to reduce any nonspecific binding to the Ni2+-NTA column.
All of the mutant ' subunits tested retained the ability to assemble
into the core enzyme demonstrated by the association of the and subunits throughout the purification (Fig.
4, A and B). Again,
mutations R275Q, E295K, and A302D caused defects in binding
70 in both log and stationary phase samples (Fig.
4C). Also reduced in E 70 formation were N266D
in both log and stationary phase samples and R297S in log phase
samples. Q300E again showed properties of binding 70
better than wild type. Y269A, K280E, R293Q, and N309D had no detectable
effect on E 70 assembly. When a
non-His6-tagged ' was expressed from the plasmid, there
was no detectable nonspecific binding to the Ni2+-NTA
column.

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 4.
Assembly of core and/or holoenzyme.
Cells grown with wt or mutant ' expression plasmids were harvested
and subjected to purification to isolate the plasmid-derived,
His6-tagged ' and any of its assembled complexes.
Proteins from Ni2+-NTA-purified samples were separated via
SDS-polyacrylamide gel electrophoresis and blotted to nitrocellulose.
The blots were then probed with monoclonal antibodies against the
indicated subunits. A, log phase samples. B,
stationary phase samples. No His6, strain expressing
plasmid-derived, wt ' without a hexahistidine tag. C,
quantitation of relative 70 binding for the mutants
versus wild type ', normalized to the amount of the subunit retained (wt = 1.0). Results are the average of three
different experiments. Error bars represent standard
deviation. D and E, log and stationary samples,
respectively, probed for minor factors.
|
|
All of the sample eluates were also assayed for the presence of any
minor species. The only minor s of which the concentrations were
sufficient for detection were 32 in log phase and
32 and F in stationary phase samples. The
results for these s were essentially the same as for
70 with the exception of mutants R297S and Q300E. In
stationary phase samples from the Q300E mutant, the 32
and F levels are greatly reduced, whereas the
70 levels are above those in the wt. The log phase
samples for this mutant also contained a decreased amount of
32 indicating a defect in E 32 formation
but not as severe as in stationary phase.
Molecular Modeling of ' Mutations--
Recently, Zhang et
al. (19) published the crystal structure of T. aquaticus core RNAP. The '260-309 region of
E. coli RNAP has a high degree of sequence conservation with
its T. aquaticus homolog (Fig.
5A).2
This region of the T. aquaticus ' subunit forms a coiled
coil-like structure. When the mutations studied here are modeled onto
the T. aquaticus structure using the Rasmol program (25),
those that are most defective in binding are grouped on one face of the coiled coil. Those that had defective phenotypes in some assays but
not others are on the outer edges of this face. Mutations that had no
detectable effects are clustered on the opposite face of the coiled
coil, with the exception of N309D, which is located at the very C
terminus of the coiled coil immediately next to the "rudder" (19)
(Fig. 5, B and
C).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 5.
Modeling of mutations. A,
protein sequence alignment of E. coli
'260-309 and the homologous region from T. aquaticus. Shaded letters represent those not identical
to E. coli. B and C, two views of
mutations modeled onto the crystal structure of T. aquaticus
core RNAP (19) using the Rasmol program (25). B, oriented
looking down the center of the coiled coil, toward the polymerase.
C, side view of the coiled coil. The mutations that were
defective in all assays tested are colored green. Mutations
that were defective in some assays, but not all, are colored
cyan. Mutations that were always functional are colored
purple. Rudder, colored maroon, is added to
orient the structure (19).
|
|
 |
DISCUSSION |
Binding of various factors to the core polymerase is a major
step in the process of global gene expression and regulation. It is not
known whether this step is part of the regulation, via a competition
for binding to a limited core population, or merely a straight-forward
binding of free s to an excess of core (27-30). If there is
competition among populations of species for core binding, that
competition may be influenced by binding specificity of the s. In
light of the high sequence conservation of most species, it has
been thought that all factors bind to the same location(s) on the
core enzyme (1). We had previously identified a binding site for
70 in vitro (14). In this report, we verify
the importance of this site for in vivo binding and
function, identify important residues for binding, define a
potential binding interface for the -core interaction, and show that
this binding site is involved in binding at least some of the minor factors.
Our mutational analysis was designed to look for loss of
70 binding by targeting residues of the 260-309 region
of the ' subunit that were identified as occupying e or g positions
in the predicted coiled coil structure. Based on our results, we have
divided the mutations into three groups: nonfunctional for binding
in all assays tested, nonfunctional in some assays but not others, and functional in all assays tested. The first group contains the mutations
R275Q, E295K, and A302D. These three mutations were nonfunctional for
70 binding in vitro and in vivo,
indicating that they play a very important role in binding
70. Arginine 275 is located near the C terminus of the
first of the two putative helices, whereas glutamate 295 and alanine
302 are in the middle and near the C terminus of the second helix, respectively. This confirms what we had found with our earlier mapping
work that both predicted helices of '260-309 were involved in binding 70. The mutations made at these
residues were the only ones tested that could not support any
detectable growth when the expression of the chromosomal ' subunit
was turned off. This is significant in light of the fact that these
mutant ' subunits, along with all those tested in this study, had no
detectable defect in interactions with the and subunits
necessary to form the core enzyme. We conclude from these results that
there are no gross folding defects that are responsible for the lack of
70 binding.
It is possible that the local structure of these mutant proteins is
disturbed. Sequence analysis of all 10 mutant subunits predicted no
change in secondary structures as compared with the wild type protein
(15, 31). The A302D change would be the most likely, though, of the
three group 1 mutations to be disturbing the local structure. This
introduces a bulky charged side chain in place of a single methyl
group. Also, based on the crystal structure of the T. aquaticus core RNAP (19), the Ala-302 carbon is directed more
toward the opposite helix of the coiled coil than are the side chains
of Arg-275 or Glu-295, which are solvent-exposed. If R275Q and E295K
are not affecting the local ' structure, then most likely, the
negative 70 binding properties are coming from steric
hindrance, charge repulsion, or loss of a specific interaction with the
subunit.
The group 2 mutants, N266D, R293Q, and R297S, are of particular
interest because they seem to have some function depending on the assay
in which they are analyzed. R293Q and R297S were not functional for
in vitro 70 binding in far Western assays but
could support growth and were able to form core enzymes that were
capable of binding 70, although R297S does cause a
decrease in the binding efficiency of the mutant core enzyme in log
phase. The differences in the in vivo and in
vitro assay results for these mutants can be explained in multiple
ways. First, a positive result from the far Western assay requires that
a ' fragment (amino acids 1-319) refold the secondary structure
needed to bind 70, whereas part of the protein is
immobilized on a membrane. Therefore, mutations found to cause defects
may be introducing in vitro folding deficiencies. Secondly,
the in vivo assays are analyzing binding to the
multisubunit core enzyme and not just an individual subunit or
fragment. A great deal of evidence has been reported suggesting multiple binding sites on core RNAP for the factor (6, 10-12). Thus, loss of one of those sites may be compensated for by the remaining binding interactions. We believe that whereas R293Q and R297S
mutations are disrupting binding to '260-309, they
are not obstructing 70 from making its other contacts on
core polymerase.
In contrast to the previous group 2 mutations, N266D had no effect on
70 binding to ' but caused reductions in
E 70 formation comparable to group 1 mutations and had a
weak growth deficiency. Asn-266 is located at the base of the coiled
coil and, when mutated, could change the local structure. This change may be causing a shift in the orientation of the coiled coil with respect to the rest of the core enzyme. This would not affect the
binding of 70 to the coiled coil but may disrupt other
contacts normally made by 70 with core.
The group 3 mutants, Y269A, K280E, Q300E, and N309D, were all fully
functional, indicating that these residues are not making critical
contacts with 70. The Q300E change was rather
interesting. This mutation seems to cause an increase in binding of
70 to '. The large increase in relative binding seen
in the far Western may not have been derived strictly from an increase
in affinity of the mutant ' fragment for 70. The '
fragment containing this mutation could be better suited than the wild
type fragment to refold its native conformation while attached to the
nitrocellulose. Therefore, a larger population of properly folded
protein may exist to bind 70. The increase in relative
70 binding by the Q300E ' mutant in the far Western
was not as dramatic in vivo possibly due to the
70-core interaction having a larger
Keq than the 70- ' interaction.
However, the assembly of E 70 for this mutant was still
almost twice that of wild type. Inhibitors based on coiled coil
interactions have proven to be useful in disrupting such processes as
viral entry into cells and topoisomerase activity (32-34). Our
laboratory has begun work to design inhibitors of the -core
interaction for potential use as antibacterial therapeutics. The Q300E
mutation may provide useful information on increasing the binding
constant of such an inhibitor.
The alternative factors have been thought to bind to the same sites
on core RNAP as 70. Mutating conserved residues of
different species will disrupt core binding (6). Traviglia et
al. (7) used tethered Fe-EDTA cleavage to determine that several
of the minor species of E. coli are in close proximity
to the same regions of core RNAP as 70 within the E
complex. We found that, at least for 32 and
F, minor factors do bind one of the same sites on
core as 70. Although they are binding to the same site,
there is some difference in the manner of binding. The Q300E mutation
that increased binding of 70 had the opposite effect,
especially in stationary phase, on 32 and
F. R297S also had different binding properties for the
factors. This mutation caused an increased binding of the minor
s and reduced binding of 70. It is interesting that
these mutations both had opposite effects on 70 and the
minor s, although only two minor s were at detectable levels.
This suggests that changes in the local environment could favor or
hinder minor binding as a whole as compared with 70.
The patterns of binding to the various ' mutants need to be determined for more of the minor s in order to substantiate this hypothesis.
Finally, the crystal structure of T. aquaticus core RNAP has
been of great utility in trying to understand the results of the
mutations. Based on the computer predictions and our mutational results, we could not have concluded that '260-309
formed a coiled coil structure. However, combining this information
with the T. aquaticus versus E. coli
' sequence alignment and the T. aquaticus crystal
structure, it is clear that '260-309 adopts a coiled
coil conformation. Upon binding, though, it is not clear what
structure this region takes on. Conserved region 2.1 of
70, implicated in core binding (8), forms a coiled coil
with region 1.2 in the crystal structure of the 70
protease-resistant domain (35). Also, a predicted coiled coil in
54 of E. coli has been found to be important
in the -core interaction (36). These factor structures may be
interacting with '260-309 to form a four-helix coiled
coil. It is also known that the factor undergoes a conformational
change upon binding core (11, 37, 38). This may be caused by a
rearrangement of the coiled coils to form new contacts (39, 40).
From the clustering of the group 1 mutations on the same face of the
coiled coil structure and the positioning of the group 2 mutations on
the edges of the cluster and the group 3 members on the opposite side
of the coiled coil, we conclude that we have defined the binding
interface for 70 on '. Recent work in our laboratory
has localized the region of 70 that is interacting with
'260-309 to a peptide containing a portion of the
nonconserved region and region 2.1 of the 70 subunit
(41). ' region 198-237 was identified by Brodolin et al.
(42) as interacting with the nontemplate strand of the lacUV5 promoter,
which also is known to be contacted by region 2.4 of 70
(43, 44). We are now in a position to model the -core interaction using these results as landmarks.
 |
ACKNOWLEDGEMENTS |
We are grateful to S. Darst for generously
providing us with the T. aquaticus core RNAP structure
coordinates. We thank K. Severinov for the T. aquaticus rpoC
gene sequence and R. Landick for gifts of strain RL602 and plasmids. We
also thank V. Svetlov and N. Thompson for technical advice and critical
reading of the manuscript.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant GM28575 (to R. R. B.) and by National Institutes of Health Biotechnology Training Grant Fellowship ST32GM08349 (to T. M. A.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: McArdle Laboratory
for Cancer Research, University of Wisconsin-Madison, 1400 University
Ave., Madison, WI 53706. Tel.: 608-263-2635; Fax: 608-262-2824; E-mail: burgess@oncology.wisc.edu.
Published, JBC Papers in Press, April 11, 2000, DOI 10.1074/jbc.M002040200
2
L. Minakhin and K. Severinov, personal communication.
 |
ABBREVIATIONS |
The abbreviations used are:
RNAP, RNA
polymerase;
Ni2+-NTA, nickel nitrilotriacetic acid;
wt, wild type.
 |
REFERENCES |
| 1.
|
Helmann, J. D.,
and Chamberlin, M. J.
(1988)
Annu. Rev. Biochem.
57,
839-872
|
| 2.
|
Burgess, R. R.,
Travers, A. A.,
Dunn, J. J.,
and Bautz, E. K. F.
(1969)
Nature
221,
43-46
|
| 3.
|
Gross, C. A.,
Chan, C. L.,
and Lonetto, M. A.
(1996)
Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci.
351,
475-482
|
| 4.
|
Gross, C. A.,
Lonetto, M.,
and Losick, R.
(1992)
in
Transcriptional Regulation
(McKnight, S.
, and Yamamoto, K., eds)
, pp. 129-176, Cold Spring Harbor Press, Cold Spring Harbor, NY
|
| 5.
|
Lonetto, M.,
Gribskov, M.,
and Gross, C. A.
(1992)
J. Bacteriol.
174,
3843-3849
|
| 6.
|
Sharp, M. M.,
Chan, C. L.,
Lu, C. Z.,
Marr, M. T.,
Nechaev, S.,
Merritt, E. W.,
Severinov, K.,
Roberts, J. W.,
and Gross, C. A.
(1999)
Genes Dev.
13,
3015-3026
|
| 7.
|
Traviglia, S. L.,
Datwyler, S. A.,
Yan, D.,
Ishihama, A.,
and Meares, C. F.
(1999)
Biochemistry
38,
15774-15778
|
| 8.
|
Lesley, S. A.,
and Burgess, R. R.
(1989)
Biochemistry
28,
7728-7734
|
| 9.
|
Shuler, M. F.,
Tatti, K. M.,
Wade, K. H.,
and Moran, C. P., Jr.
(1995)
J. Bacteriol.
177,
3687-3694
|
| 10.
|
Joo, D. M.,
Nolte, A.,
Calendar, R.,
Zhou, Y. N.,
and Jin, D. J.
(1998)
J. Bacteriol.
180,
1095-1102
|
| 11.
|
Nagai, H.,
and Shimamoto, N.
(1997)
Genes Cells
2,
725-734
|
| 12.
|
Owens, J. T.,
Miyake, R.,
Murakami, K.,
Chmura, A. J.,
Fujita, N.,
Ishihama, A.,
and Meares, C F.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
6021-6026
|
| 13.
|
Fisher, R.,
and Blumenthal, T.
(1980)
J. Biol. Chem.
255,
11056-11062
|
| 14.
|
Arthur, T. M.,
and Burgess, R. R.
(1998)
J. Biol. Chem.
273,
31381-31387
|
| 15.
|
Rost, B.,
Sander, C.,
and Schneider, R.
(1994)
CABIOS
10,
53-60
|
| 16.
|
Lupas, A.,
Van Dyke, M.,
and Stock, J.
(1991)
Science
252,
1162-1164
|
| 17.
|
Cohen, C.,
and Parry, D. A. D.
(1986)
Trends Biochem. Sci.
11,
245-248
|
| 18.
|
Chao, H.,
Bautista, D. L.,
Litowski, J.,
Irvin, R. T.,
and Hodges, R. S.
(1998)
J. Chromatogr. B Biomed. Sci. Appl.
715,
307-329
|
| 19.
|
Zhang, G.,
Campbell, E. A.,
Minakhin, L.,
Richter, C.,
Severinov, K.,
and Darst, S. A.
(1999)
Cell
98,
811-824
|
| 20.
|
Wang, D.,
Meier, T. I.,
Chan, C. L.,
Feng, G.,
Lee, D. N.,
and Landick, R. L.
(1995)
Cell
81,
341 350
|
| 21.
|
Gribskov, M.,
and Burgess, R. R.
(1986)
Nucleic Acids Res.
14,
6745-6763
|
| 22.
|
Weilbaecher, R.,
Hebron, C.,
Feng, G.,
and Landick, R.
(1994)
Genes Dev.
8,
2913-2917
|
| 23.
|
Ridley, S. P.,
and Oeshger, M. P.
(1982)
J. Bacteriol.
152,
736-746
|
| 24.
|
Thompson, N. E.,
Hager, D. A.,
and Burgess, R. R.
(1992)
Biochemistry
31,
7003-7008
|
| 25.
|
Sayle, R. A.,
and Milner-White, E. J.
(1995)
Trends Biochem. Sci.
20,
374
|
| 26.
|
Bogan, A. A.,
and Thorn, K. S.
(1998)
J. Mol. Biol.
280,
1-9
|
| 27.
|
Jishage, M.,
Iwata, A.,
Ueda, S.,
and Ishihama, A.
(1996)
J. Bacteriol.
178,
5447-5451
|
| 28.
|
Ju, J.,
Mitchell, T.,
Peters, H., III,
and Haldenwang, W. G.
(1999)
J. Bacteriol.
181,
4969-4977
|
| 29.
|
Farewell, A.,
Kvint, K.,
and Nystrom, T.
(1998)
Mol. Microbiol.
29,
1039-1051
|
| 30.
|
Fujita, M.
(2000)
Genes Cells
5,
79-88
|
| 31.
|
Muñoz, V.,
and Serrano, L.
(1994)
Nat. Struct. Biol.
1,
399-409
|
| 32.
|
Eckert, D. M.,
Malashkevich, V. N.,
Hong, L. H.,
Carr, P. A.,
and Kim, P. S.
(1999)
Cell
99,
103-115
|
| 33.
|
Wild, C. T.,
Shugars, D. C.,
Greenwell, T. K.,
McDanal, C. B.,
and Matthews, T. J.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
9770-9774
|
| 34.
|
Frere-Gallois, V.,
Krebs, D.,
Scala, D.,
Troalen, F.,
and Fermandjian, S.
(1997)
Eur. J. Biochem
249,
142-148
|
| 35.
|
Malhotra, A.,
Severinova, E.,
and Darst, S. A.
(1996)
Cell
87,
127-136
|
| 36.
|
Hsieh, M.,
Hsu, H.,
Hwang, S.,
Wen, F., Yu, J.,
Wen, C.,
and Li, C.
(1999)
Microbiology
145,
3081-3088
|
| 37.
|
Callaci, S.,
Heyduk, E.,
and Heyduk, T.
(1998)
J. Biol. Chem.
273,
32995-33001
|
| 38.
|
McMahan, S. A.,
and Burgess, R. R.
(1999)
Biochemistry
38,
12424-12431
|
| 39.
|
Grum, V. L.,
Li, D.,
MacDonald, R. I.,
and Mondragon, A.
(1999)
Cell
98,
523-535
|
| 40.
|
El-Kettani, M. A.,
and Smith, J. C.
(1996)
C. R. Acad. Sci. III
319,
161-169
|
| 41.
|
Burgess, R. R.,
Arthur, T. M.,
and Pietz, B. C.
(1998)
Cold Spring Harbor Symp. Quant. Biol.
63,
277-287
|
| 42.
|
Brodolin, K.,
Mustaev, A.,
Severinov, K.,
and Nikiforov, V.
(2000)
J. Biol. Chem.
275,
3661-3666
|
| 43.
|
Siegele, D. A.,
Hu, J. C.,
Walter, W. A.,
and Gross, C. A.
(1989)
J. Mol. Biol.
206,
591-603
|
| 44.
|
Waldburger, C.,
Gardella, T.,
Wong, R.,
and Susskind, M. M.
(1990)
J. Mol. Biol.
215,
267-276
|
| 45.
|
Jokerst, R. S.,
Weeks, J. R.,
Zehring, W. A.,
and Greenleaf, A. L.
(1989)
Mol. Gen. Genet.
215,
266 275
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. R. MacLellan, J. D. Helmann, and H. Antelmann
The YvrI Alternative {sigma} Factor Is Essential for Acid Stress Induction of Oxalate Decarboxylase in Bacillus subtilis
J. Bacteriol.,
February 1, 2009;
191(3):
931 - 939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sevostyanova, V. Svetlov, D. G. Vassylyev, and I. Artsimovitch
The elongation factor RfaH and the initiation factor {sigma} bind to the same site on the transcription elongation complex
PNAS,
January 22, 2008;
105(3):
865 - 870.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. V. McDowell, M. E. Harlin, E. A. Rogers, and R. T. Marconi
Putative Coiled-Coil Structural Elements of the BBA68 Protein of Lyme Disease Spirochetes Are Required for Formation of Its Factor H Binding Site
J. Bacteriol.,
February 15, 2005;
187(4):
1317 - 1323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Berghofer-Hochheimer, C. Z. Lu, and C. A. Gross
Altering the interaction between {sigma}70 and RNA polymerase generates complexes with distinct transcription-elongation properties
PNAS,
January 25, 2005;
102(4):
1157 - 1162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mahren and V. Braun
The FecI Extracytoplasmic-Function Sigma Factor of Escherichia coli Interacts with the {beta}' Subunit of RNA Polymerase
J. Bacteriol.,
March 15, 2003;
185(6):
1796 - 1802.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Bergendahl, T. Heyduk, and R. R. Burgess
Luminescence Resonance Energy Transfer-Based High-Throughput Screening Assay for Inhibitors of Essential Protein-Protein Interactions in Bacterial RNA Polymerase
Appl. Envir. Microbiol.,
March 1, 2003;
69(3):
1492 - 1498.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Wong, G. A. Kassavetis, J.-P. Leonetti, and E. P. Geiduschek
Mutational and Functional Analysis of a Segment of the Sigma Family Bacteriophage T4 Late Promoter Recognition Protein gp55
J. Biol. Chem.,
February 21, 2003;
278(9):
7073 - 7080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Anthony and R. R. Burgess
Conformational Flexibility in sigma 70 Region 2 during Transcription Initiation
J. Biol. Chem.,
November 22, 2002;
277(48):
46433 - 46441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Murakami, S. Masuda, and S. A. Darst
Structural Basis of Transcription Initiation: RNA Polymerase Holoenzyme at 4 A Resolution
Science,
May 17, 2002;
296(5571):
1280 - 1284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Anthony, A. A. Dombkowski, and R. R. Burgess
Using Disulfide Bond Engineering To Study Conformational Changes in the {beta}'260-309 Coiled-Coil Region of Escherichia coli RNA Polymerase during {sigma}70 Binding
J. Bacteriol.,
May 15, 2002;
184(10):
2634 - 2641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Chan and C. A. Gross
The Anti-initial Transcribed Sequence, a Portable Sequence That Impedes Promoter Escape, Requires sigma 70 for Function
J. Biol. Chem.,
October 5, 2001;
276(41):
38201 - 38209.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|